JP Stock MarketDetailed Quotes

4598 Delta-Fly Pharma

Watchlist

572
+6+1.06%

20min DelayMarket Closed Aug 16 15:00 JST

4.71BMarket Cap-2877P/E (Static)

Delta-Fly Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(FY)Mar 31, 2022

(FY)Mar 31, 2021

Total revenue

0.00%300M

200.00%300M

Cost of revenue

Gross profit

Operating expense

6.66%1.4B

56.88%454.07M

-14.18%355.94M

317.87M

275.58M

4.31%1.32B

289.44M

414.74M

9.48%1.26B

-29.98%1.15B

Selling and administrative expenses

-6.29%284.85M

5.99%76.46M

-9.74%71.13M

--68.19M

--69.07M

-5.21%303.98M

--72.14M

--78.81M

12.40%320.68M

15.03%285.31M

-General and administrative expense

-6.29%284.85M

5.99%76.46M

-9.74%71.13M

--68.19M

--69.07M

-5.21%303.98M

--72.14M

--78.81M

12.40%320.68M

15.03%285.31M

Research and development costs

10.55%1.12B

73.77%377.61M

-15.22%284.81M

--249.68M

--206.51M

7.55%1.01B

--217.3M

--335.93M

8.52%940.79M

-37.97%866.92M

Operating profit

-6.66%-1.4B

-56.88%-454.07M

14.18%-355.94M

-317.87M

-275.58M

-36.86%-1.32B

-289.44M

-414.74M

-12.82%-961.46M

44.86%-852.23M

Net non-operating interest income (expenses)

-320.65%-17.64M

100.64%8K

-471.86%-16.87M

-786K

-131.84%-4.19M

-1.25M

-2.95M

53.93%-1.81M

-3,314.78%-3.93M

Non-operating interest income

7.69%14K

33.33%8K

--0

--6K

--0

-81.43%13K

--6K

--0

-69.16%70K

-65.08%227K

Non-operating interest expense

----

-74.71%43K

Total other finance cost

319.68%17.66M

--0

--16.87M

--0

--786K

123.90%4.21M

--1.26M

----

-54.29%1.88M

590.92%4.11M

Net investment income

0.02%-5.79M

-323.85%-1.8M

-70.03%824K

-1.13M

-3.68M

-533.15%-5.79M

805K

2.75M

73.31%-914K

48.36%-3.42M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

Special income (charges)

Other non-operating income (expenses)

-96.88%1K

-73.33%32K

24K

-43.13%120K

339.58%211K

Income before tax

-7.63%-1.43B

-57.27%-455.87M

10.35%-371.99M

-319M

-280.04M

-37.52%-1.33B

-289.86M

-414.94M

-12.18%-964.06M

44.64%-859.37M

Income tax

-17.37%2.5M

0.16%626K

-19.35%625K

626K

625K

-6.46%3.03M

625K

775K

0.75%3.24M

-9.80%3.21M

Net income

-7.57%-1.43B

-57.15%-456.49M

10.37%-372.61M

-319.62M

-280.67M

-37.37%-1.33B

-290.49M

-415.71M

-12.14%-967.3M

44.56%-862.59M

Net income continuous operations

-7.57%-1.43B

-57.15%-456.49M

10.37%-372.61M

---319.62M

---280.67M

-37.37%-1.33B

---290.49M

---415.71M

-12.14%-967.3M

44.56%-862.59M

Noncontrolling interests

Net income attributable to the company

-7.57%-1.43B

-57.15%-456.49M

10.37%-372.61M

-319.62M

-280.67M

-37.37%-1.33B

-290.49M

-415.71M

-12.14%-967.3M

44.56%-862.59M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-7.57%-1.43B

-57.15%-456.49M

10.37%-372.61M

-319.62M

-280.67M

-37.37%-1.33B

-290.49M

-415.71M

-12.14%-967.3M

44.56%-862.59M

Gross dividend payment

Basic earnings per share

15.24%-198.78

-27.88%-56.69

33.37%-50.17

-48.85

-43.07

-31.32%-234.51

-44.33

-75.3

4.68%-178.58

46.22%-187.34

Diluted earnings per share

15.24%-198.78

-24.30%-56.69

34.60%-50.17

-48.85

-43.07

-31.32%-234.51

-45.607

-76.7079

4.68%-178.58

46.22%-187.34

Dividend per share

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(FY)Mar 31, 2022	(FY)Mar 31, 2021
Total revenue	0	0	0	0	0	0	0	0	0.00%300M	200.00%300M
Cost of revenue
Gross profit
Operating expense	6.66%1.4B	56.88%454.07M	-14.18%355.94M	317.87M	275.58M	4.31%1.32B	289.44M	414.74M	9.48%1.26B	-29.98%1.15B
Selling and administrative expenses	-6.29%284.85M	5.99%76.46M	-9.74%71.13M	--68.19M	--69.07M	-5.21%303.98M	--72.14M	--78.81M	12.40%320.68M	15.03%285.31M
-General and administrative expense	-6.29%284.85M	5.99%76.46M	-9.74%71.13M	--68.19M	--69.07M	-5.21%303.98M	--72.14M	--78.81M	12.40%320.68M	15.03%285.31M
Research and development costs	10.55%1.12B	73.77%377.61M	-15.22%284.81M	--249.68M	--206.51M	7.55%1.01B	--217.3M	--335.93M	8.52%940.79M	-37.97%866.92M
Operating profit	-6.66%-1.4B	-56.88%-454.07M	14.18%-355.94M	-317.87M	-275.58M	-36.86%-1.32B	-289.44M	-414.74M	-12.82%-961.46M	44.86%-852.23M
Net non-operating interest income (expenses)	-320.65%-17.64M	100.64%8K	-471.86%-16.87M	6K	-786K	-131.84%-4.19M	-1.25M	-2.95M	53.93%-1.81M	-3,314.78%-3.93M
Non-operating interest income	7.69%14K	33.33%8K	--0	--6K	--0	-81.43%13K	--6K	--0	-69.16%70K	-65.08%227K
Non-operating interest expense	----	----	----	----	----	----	----	----	----	-74.71%43K
Total other finance cost	319.68%17.66M	--0	--16.87M	--0	--786K	123.90%4.21M	--1.26M	----	-54.29%1.88M	590.92%4.11M
Net investment income	0.02%-5.79M	-323.85%-1.8M	-70.03%824K	-1.13M	-3.68M	-533.15%-5.79M	805K	2.75M	73.31%-914K	48.36%-3.42M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)
Other non-operating income (expenses)	-96.88%1K	0	0			-73.33%32K	24K	0	-43.13%120K	339.58%211K
Income before tax	-7.63%-1.43B	-57.27%-455.87M	10.35%-371.99M	-319M	-280.04M	-37.52%-1.33B	-289.86M	-414.94M	-12.18%-964.06M	44.64%-859.37M
Income tax	-17.37%2.5M	0.16%626K	-19.35%625K	626K	625K	-6.46%3.03M	625K	775K	0.75%3.24M	-9.80%3.21M
Net income	-7.57%-1.43B	-57.15%-456.49M	10.37%-372.61M	-319.62M	-280.67M	-37.37%-1.33B	-290.49M	-415.71M	-12.14%-967.3M	44.56%-862.59M
Net income continuous operations	-7.57%-1.43B	-57.15%-456.49M	10.37%-372.61M	---319.62M	---280.67M	-37.37%-1.33B	---290.49M	---415.71M	-12.14%-967.3M	44.56%-862.59M
Noncontrolling interests
Net income attributable to the company	-7.57%-1.43B	-57.15%-456.49M	10.37%-372.61M	-319.62M	-280.67M	-37.37%-1.33B	-290.49M	-415.71M	-12.14%-967.3M	44.56%-862.59M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	-7.57%-1.43B	-57.15%-456.49M	10.37%-372.61M	-319.62M	-280.67M	-37.37%-1.33B	-290.49M	-415.71M	-12.14%-967.3M	44.56%-862.59M
Gross dividend payment
Basic earnings per share	15.24%-198.78	-27.88%-56.69	33.37%-50.17	-48.85	-43.07	-31.32%-234.51	-44.33	-75.3	4.68%-178.58	46.22%-187.34
Diluted earnings per share	15.24%-198.78	-24.30%-56.69	34.60%-50.17	-48.85	-43.07	-31.32%-234.51	-45.607	-76.7079	4.68%-178.58	46.22%-187.34
Dividend per share
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall